Table 3.
Lesioned hemisphere cortical excitability mapping measures.
| ID | Laterality | Mapping testing intensity (% MSO) | Lesioned hemisphere | ||||
|---|---|---|---|---|---|---|---|
| Pretest FDI sites | Pretest FDI mapping latency (ms) | Posttest FDI sites | Posttest FDI mapping latency (ms) | % ∆ in FDI sites | |||
| 1 | Contralateral | † | † | † | † | † | † |
| 2 | Contralateral | 48 | 24 | 22.50 | 18 | 20.19 | −25.00 |
| 3 | Contralateral | 70 | 24 | 27.06 | 23 | 25.26 | −4.17 |
| 4 | Bilateral | † | † | † | † | † | † |
| 5 | Bilateral | 51 | 39 | 49.95 | 57 | 47.51 | 46.15 |
| 6 | Bilateral | 38 | 38 | 58.00 | 27 | 58.36 | −28.95 |
| 7 | Bilateral | † | † | † | † | † | † |
| 8 | Bilateral | † | † | † | † | † | † |
FDI: first dorsal interosseous; ID: participant identifier; ms: milliseconds; NA: not assessed at baseline; NC: not calculated due to missing baseline data; RMT: resting motor threshold; ∆: change; †: missing data; % MSO: percentage of maximum stimulator output. Motor mapping testing intensity was 110% RMT (resting motor threshold). MEP latency durations are reported using the mean time (ms). Bolded values are considered significant defined as ≥20% mapping response sites.